DAOIB
5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
5
Ongoing
1
Recruiting
1
Completed
3
Sites
4
Countries
1
Endpoints
30
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 30 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 5 of 30 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
5
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
5 of 5
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| NCT02103673DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia | DAOIB Alzheimer’s disease, Vascular cognitive impairment / dementia | Multiple dementia etiologies | Ph 2 | Completed | 2 | Nov 2017 | 2 | |
| NCT05582161Efficacy Biomarkers of DAOIB for Dementia | DAOIB Alzheimer’s disease, MCI / preclinical Alzheimer’s | Alzheimer's disease | Ph 2 | Recruiting | 2 | Sep 2026 | - | |
| NCT01600469NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease | DAOIB Alzheimer’s disease, MCI / preclinical Alzheimer’s | Alzheimer's disease | Ph 2 | Completed | 1 | May 2013 | - | |
| NCT04737096DAOIB Combined With tDCS for Early-phase Dementia | DAOIB Alzheimer’s disease, MCI / preclinical Alzheimer’s | Alzheimer's disease | Ph 2 | Completed | 1 | Jan 2023 | - | |
| NCT05006781The Dose Finding Study of DAOIB Added to tDCS for AD | DAOIB Alzheimer’s disease | Alzheimer's disease | Ph 2 | Suspended | 1 | Dec 2028 | - |
Showing 1-5 of 5 trials